arrow
A

André Mattar

hospital da mulher
H指数:12
被引数:774

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ASO Visual Abstract: Cavity Margins Sample Shaving Evaluation as Part of Vacuum-Assisted Breast Biopsy: A Potential Approach to Predict Breast Cancer Excision

ASO视觉摘要:作为真空辅助乳腺活检的一部分,评估腔隙边缘样本刮取作为预测乳腺癌切除的潜在方法

2026-09-280
PRE
Cavity Margins Sample Shaving as Part of Extended Vacuum-Assisted Breast Biopsy: A Potential Approach to Predict Percutaneous Breast Cancer Excision

腔缘样本刮取作为扩展真空辅助乳腺活检的一部分:一种预测经皮乳腺癌切除术的潜在方法

2026-08-280
OAAI
Final analysis of the FeDeriCa phase III study: long-term efficacy, safety and pharmacokinetics of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection, plus chemotherapy, in HER2-positive early breast cancer

FeDeriCa III期研究的最终分析:在HER2阳性早期乳腺癌患者中,曲妥珠单抗和帕妥珠单抗固定剂量联合皮下注射方案联合化疗的长期疗效、安全性和药代动力学

2026-07-310
OA
Reoperation rates following breast-conserving surgery in a contemporary cohort

当代队列中保乳术后再手术率

2026-05-190
PRE
Severe Adverse Events in Neoadjuvant Therapy of Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Phase 3 Trials

三阴性乳腺癌新辅助治疗中的严重不良事件:一项针对随机III期试验的系统评价和荟萃分析

2026-04-280
OAAI
Clinical characteristics and prognostic impact of HER2 low expression in breast cancer subtypes from a Brazilian real-world cohort

HER2低表达在不同乳腺癌亚型中的临床特征及其预后影响:一项来自巴西真实世界队列的研究

2025-12-120
OAAI
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: 1-Year Follow-Up After Final Analysis of the ENGOT-en9/LEAP-001 Phase 3 Trial

一线仑伐替尼联合帕博利珠单抗与化疗治疗晚期子宫内膜癌:ENGOT-en9/LEAP-001 III期试验最终分析后的1年随访

2025-11-110
PRE
Immunohistochemical Changes After Neoadjuvant Chemotherapy and Their Impact on Breast Cancer Survival: A Systematic Review and Meta-analysis

新辅助化疗后的免疫组织化学变化及其对乳腺癌生存的影响:一项系统评价和Meta分析

2025-11-010
PRE
Vacuum-assisted excision: one-step approach to the diagnosis and percutaneous treatment of small early breast cancer (the VAE-BREAST 01 study protocol)

真空辅助切除术:早期小乳腺癌诊断和经皮治疗的一步法(VAE-BREAST 01研究方案)

2025-10-240
OAAI
Prognostic Impact of Real-World Immunohistochemical Changes in Breast Cancer Treated with Neoadjuvant Chemotherapy

新辅助化疗治疗乳腺癌中真实世界免疫组织化学变化对预后的影响

2025-07-300
PRE
Twenty years of breast cancer epidemiology and treatment patterns in São Paulo, Brazil-observed versus expected treatment utilization in a retrospective cohort

巴西圣保罗地区二十年乳腺癌流行病学及治疗模式——回顾性队列研究中观察到的与预期治疗利用率比较

2025-07-010
OA
CADONOT: Comparing axillary dissection or not in breast cancer surgery

CADONOT:比较乳腺手术中是否进行腋窝清扫

BREAST
IF7.9
2025-06-010
OAAI
Disparities in access to anti-HER2 therapies in neoadjuvant chemotherapy: A prognostic analysis based on real-world data comparing Brazil's public and private healthcare systems
BREAST
IF7.9
2025-04-010
OAAI
Oncological outcomes of breast-conserving surgery versus mastectomy following neoadjuvant chemotherapy in a contemporary multicenter cohort

在当代多中心队列中,新辅助化疗后保乳手术与乳房切除术的肿瘤学结果

2025-03-160
OAAI
Comparative Analyses of Van Nuys Prognostic Index and NCCN Guidelines in Ductal Carcinoma In Situ Treatment in a Brazilian Hospital
2025-03-090
OAAI
The relationship between body mass index and pathological complete response in Brazilian breast cancer patients

巴西乳腺癌患者体重指数与病理完全缓解的关系

2025-02-200
OAAI
Breast and axillary marking in the neoadjuvant setting: survey results from experts of the Brazilian society of mastology
2024-10-090
OAAI
ASO Visual Abstract: PROMRIINE (PRe-operatory Magnetic Resonance Imaging is INEffective) Study: A Systematic Review and Meta-analysis of the Impact of Magnetic Resonance Imaging on Surgical Decisions and Clinical Outcomes in Women with Breast Cancer
2024-08-060
PRE